ArticleJournal of molecular modeling2022

Discovery of novel targets and mechanisms of MEK inhibitor Selumetinib for LGG treatment based on molecular docking and molecular dynamics simulation.

Dongdong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.